OXYCODONE AND ACETAMINOPHEN
Generic: OXYCODONE AND ACETAMINOPHEN
Camber PharmaceuticalsManufacturer
ORALRoute
OXYCODONE HYDROCHLORIDEActive Substance
2017-03-22Original Approval
OXYCODONE AND ACETAMINOPHEN is FDA application ANDA207419, sponsored by ASCENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-12-16
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDFailed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Class II2025-12-16
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Class II2020-03-18
Oxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA,CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Top Reported Reactions
1
PAIN
1,502 reports
2
FATIGUE
1,459 reports
3
DRUG INEFFECTIVE
1,446 reports
4
DYSPNOEA
1,082 reports
5
NAUSEA
1,007 reports
6
ARTHRALGIA
986 reports
7
HEADACHE
920 reports
8
RASH
883 reports
9
PRURITUS
867 reports
10
PYREXIA
835 reports